Market Value7,798,795,162
Total Holdings75
File Date2024-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ABOS / Acumen Pharmaceuticals, Inc.
MGX / Metagenomi Therapeutics, Inc.
ITOS / iTeos Therapeutics, Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
NAMS.W / NewAmsterdam Pharma Company N.V. - Equity Warrant
GHRS / GH Research PLC
MGNX / MacroGenics, Inc.
TYRA / Tyra Biosciences, Inc.
SPRY / ARS Pharmaceuticals, Inc.
AXSM / Axsome Therapeutics, Inc.
CMRX / Chimerix, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
CVAC / CureVac N.V.
HOWL / Werewolf Therapeutics, Inc.
URGN / UroGen Pharma Ltd.
LBPH / Longboard Pharmaceuticals, Inc.
APGE / Apogee Therapeutics, Inc.
IMTX / Immatics N.V.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
RYTM / Rhythm Pharmaceuticals, Inc.
ANTX / AN2 Therapeutics, Inc.
WVE / Wave Life Sciences Ltd.
RGLS / Regulus Therapeutics Inc.
SERA / Sera Prognostics, Inc.
ETNB / 89bio, Inc.
DYN / Dyne Therapeutics, Inc.
ATXS / Astria Therapeutics, Inc.
FULC / Fulcrum Therapeutics, Inc.
UNCY / Unicycive Therapeutics, Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
ASND / Ascendis Pharma A/S
ELYM / Eliem Therapeutics, Inc.
CBAY / CymaBay Therapeutics, Inc.
ALPN / Alpine Immune Sciences, Inc.
IMGN / ImmunoGen, Inc.
CNTB / Connect Biopharma Holdings Limited
/ Harpoon Therapeutics Inc
ICVX / Icosavax, Inc.
SABS / SAB Biotherapeutics, Inc.
CTKB / Cytek Biosciences, Inc.
ACET / Adicet Bio, Inc.
PLRX / Pliant Therapeutics, Inc.
RXST / RxSight, Inc.
ELVN / Enliven Therapeutics, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
TSHA / Taysha Gene Therapies, Inc.
CRVO / CervoMed Inc.
CYBN / Cybin Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
BOLD / Boundless Bio, Inc.
INBX.V / Inhibrx, Inc.
IGMS / IGM Biosciences, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
PRAX / Praxis Precision Medicines, Inc.
BIIB / Biogen Inc.
LXEO / Lexeo Therapeutics, Inc.
THRD / Third Harmonic Bio, Inc.
EYPT / EyePoint, Inc.
AVTE / Aerovate Therapeutics, Inc.
TNYA / Tenaya Therapeutics, Inc.
ANRO / Alto Neuroscience, Inc.
ACRV / Acrivon Therapeutics, Inc.
GERN / Geron Corporation
CCCC / C4 Therapeutics, Inc.
MLYS / Mineralys Therapeutics, Inc.
LRMR / Larimar Therapeutics, Inc.
SLDB / Solid Biosciences Inc.
ARVN / Arvinas, Inc.
FDMT / 4D Molecular Therapeutics, Inc.
JANX / Janux Therapeutics, Inc.
VOR / Vor Biopharma Inc.
PCVX / Vaxcyte, Inc.
PEPG / PepGen Inc.
NKTX / Nkarta, Inc.
RNA / Atrium Therapeutics, Inc.
EVH / Evolent Health, Inc.
BDTX / Black Diamond Therapeutics, Inc.
LENZ / LENZ Therapeutics, Inc.
NAMS / NewAmsterdam Pharma Company N.V.
DNTH / Dianthus Therapeutics, Inc.
EWTX / Edgewise Therapeutics, Inc.
VXRT / Vaxart, Inc.